Antiproliferative, antiangiogenic and proapoptotic activity of h-R3: A humanized anti-EGFR antibody
Author:
Funder
YM BioSciences Inc., Toronto, ON, Canada
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference48 articles.
1. The role of oncogenic kinases in human cancer;Tsatsanis;Int J Mol Med,2000
2. Ras signaling pathway proteins as therapeutic targets;Adjei;Curr Pharm Des,2001
3. Tyrosine kinase inhibitors: from rational design to clinical trials;Traxler;Med Res Rev,2001
4. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001
5. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications;Tuveson;Oncogene,2000
Cited by 144 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unveiling the regulatory mechanism of nimotuzumab on PD-L1 expression in head and neck squamous cell carcinoma patients: Implications for enhanced anticancer treatment strategies;Cellular Signalling;2024-09
2. Drug Delivery Opportunities in Esophageal Cancer: Current Treatments and Future Prospects;Molecular Pharmaceutics;2024-06-18
3. Tislelizumab plus nimotuzumab is effective against recurrent or metastatic oral squamous cell carcinoma among patients with a performance status score ≥ 2: a retrospective study;Frontiers in Oncology;2024-01-16
4. Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis;Journal of Cancer Research and Clinical Oncology;2022-10-27
5. Plasma, cancer, immunity;Journal of Physics D: Applied Physics;2022-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3